Literature DB >> 26493047

Prenatal education for congenital toxoplasmosis.

Simona Di Mario1, Vittorio Basevi, Carlo Gagliotti, Daniela Spettoli, Gianfranco Gori, Roberto D'Amico, Nicola Magrini.   

Abstract

BACKGROUND: Congenital toxoplasmosis is considered a rare but potentially severe infection. Prenatal education about congenital toxoplasmosis could be the most efficient and least harmful intervention, yet its effectiveness is uncertain.
OBJECTIVES: To assess the effects of prenatal education for preventing congenital toxoplasmosis. SEARCH
METHODS: We searched the Cochrane Pregnancy and Childbirth Group's Trials Register (31 May 2015), and reference lists of relevant papers, reviews and websites. SELECTION CRITERIA: Randomized and quasi-randomized controlled trials of all types of prenatal education on toxoplasmosis infection during pregnancy. Cluster-randomized trials were eligible for inclusion. DATA COLLECTION AND ANALYSIS: Two review authors independently assessed trials for inclusion and risk of bias, extracted data and checked them for accuracy. MAIN
RESULTS: Two cluster-randomized controlled trials (RCTs) (involving a total of 5455 women) met the inclusion criteria. The two included trials measured the effectiveness of the intervention in different ways, which meant that meta-analysis of the results was not possible. The overall quality of the two studies, as assessed using the GRADE approach, was low, with high risk of detection and attrition bias in both included trials.One trial (432 women enrolled) conducted in Canada was judged of low methodological quality. This trial did not report on any of the review's pre-specified primary outcomes and the secondary outcomes reported results only as P values. Moreover, losses to follow-up were high (34%, 147 out of 432 women initially enrolled). The authors concluded that prenatal education can effectively change pregnant women's behavior as it increased pet, personal and food hygiene. The second trial conducted in France was also judged of low methodological quality. Losses to follow-up were also high (44.5%, 2233 out of 5023 women initially enrolled) and differential (40% in the intervention group and 52% in the control group). The authors concluded that prenatal education for congenital toxoplasmoses has a significant effect on improving women's knowledge, whereas it has no effect on changing women's behavior. In this trial 17/3949 pregnant women seroconverted for toxoplasmosis: 13/2591 (0.5%) in the intervention group and 4/1358 (0.3%) in the control group. The rate of seroconversion detected during the study did not differ between groups (risk ratio (RR) 1.70, 95% confidence interval (CI) 0.56 to 5.21; participants = 3949; studies = one, low quality evidence). The number of events was too small to reach conclusions about the effect of prenatal education on seroconversion rate during pregnancy.No other randomized trials on the effect of prenatal education on congenital toxoplasmosis rate, or toxoplasmosis seroconversion rate during pregnancy were detected. AUTHORS'
CONCLUSIONS: Even though primary prevention of congenital toxoplasmosis is considered a desirable intervention, given the lack of related risks compared to secondary and tertiary prevention, its effectiveness has not been adequately evaluated. There is very little evidence from RCTs that prenatal education is effective in reducing congenital toxoplasmosis even though evidence from observational studies suggests it is. Given the lack of good evidence supporting prenatal education for congenital toxoplasmosis prevention, further RCTs are needed to confirm any potential benefits and to further quantify the impact of different sets of educational intervention.

Entities:  

Mesh:

Year:  2015        PMID: 26493047      PMCID: PMC9272404          DOI: 10.1002/14651858.CD006171.pub4

Source DB:  PubMed          Journal:  Cochrane Database Syst Rev        ISSN: 1361-6137


  39 in total

Review 1.  Contamination in trials: is cluster randomisation the answer?

Authors:  D J Torgerson
Journal:  BMJ       Date:  2001-02-10

2.  Comparison of two widely used PCR primer systems for detection of toxoplasma in amniotic fluid, blood, and tissues.

Authors:  Elisabeth Chabbert; Laurence Lachaud; Lucien Crobu; Patrick Bastien
Journal:  J Clin Microbiol       Date:  2004-04       Impact factor: 5.948

3.  Epidemiological study of latent and recent infection by Toxoplasma gondii in pregnant women from a regional population in the U.K.

Authors:  J P Allain; C R Palmer; G Pearson
Journal:  J Infect       Date:  1998-03       Impact factor: 6.072

4.  Mother-to-child transmission of toxoplasmosis: risk estimates for clinical counselling.

Authors:  D Dunn; M Wallon; F Peyron; E Petersen; C Peckham; R Gilbert
Journal:  Lancet       Date:  1999-05-29       Impact factor: 79.321

5.  Feasibility of neonatal screening for toxoplasma infection in the absence of prenatal treatment. Danish Congenital Toxoplasmosis Study Group .

Authors:  M Lebech; O Andersen; N C Christensen; J Hertel; H E Nielsen; B Peitersen; C Rechnitzer; S O Larsen; B Nørgaard-Pedersen; E Petersen
Journal:  Lancet       Date:  1999-05-29       Impact factor: 79.321

Review 6.  Treatments for toxoplasmosis in pregnancy.

Authors:  F Peyron; M Wallon; C Liou; P Garner
Journal:  Cochrane Database Syst Rev       Date:  2000

7.  Prenatal diagnosis of congenital toxoplasmosis: a multicenter evaluation of different diagnostic parameters.

Authors:  W Foulon; J M Pinon; B Stray-Pedersen; A Pollak; M Lappalainen; A Decoster; I Villena; P A Jenum; M Hayde; A Naessens
Journal:  Am J Obstet Gynecol       Date:  1999-10       Impact factor: 8.661

8.  Risk factors for Toxoplasma gondii infection in mothers of infants with congenital toxoplasmosis: Implications for prenatal management and screening.

Authors:  Kenneth M Boyer; Ellen Holfels; Nancy Roizen; Charles Swisher; Douglas Mack; Jack Remington; Shawn Withers; Paul Meier; Rima McLeod
Journal:  Am J Obstet Gynecol       Date:  2005-02       Impact factor: 8.661

9.  Prevention of toxoplasmosis during pregnancy--an epidemiologic survey over 22 consecutive years.

Authors:  Maria Breugelmans; Anne Naessens; Walter Foulon
Journal:  J Perinat Med       Date:  2004       Impact factor: 1.901

Review 10.  Psychosocial interventions for supporting women to stop smoking in pregnancy.

Authors:  Catherine Chamberlain; Alison O'Mara-Eves; Sandy Oliver; Jenny R Caird; Susan M Perlen; Sandra J Eades; James Thomas
Journal:  Cochrane Database Syst Rev       Date:  2013-10-23
View more
  6 in total

1.  A social cost-benefit analysis of two One Health interventions to prevent toxoplasmosis.

Authors:  Anita W M Suijkerbuijk; Eelco A B Over; Marieke Opsteegh; Huifang Deng; Paul F van Gils; Axel A Bonačić Marinović; Mattijs Lambooij; Johan J Polder; Talitha L Feenstra; Joke W B van der Giessen; G Ardine de Wit; Marie-Josee J Mangen
Journal:  PLoS One       Date:  2019-05-10       Impact factor: 3.240

Review 2.  National perinatal survey demonstrates a decreasing seroprevalence of Toxoplasma gondii infection among pregnant women in France, 1995 to 2016: impact for screening policy.

Authors:  Eve Robinson; Henriette de Valk; Isabelle Villena; Yann Le Strat; Mathieu Tourdjman
Journal:  Euro Surveill       Date:  2021-02

Review 3.  Congenital Toxoplasmosis: The State of the Art.

Authors:  Lina Bollani; Cinzia Auriti; Cristian Achille; Francesca Garofoli; Domenico Umberto De Rose; Valeria Meroni; Guglielmo Salvatori; Chryssoula Tzialla
Journal:  Front Pediatr       Date:  2022-07-06       Impact factor: 3.569

4.  A multicenter survey on toxoplasmosis knowledge among pregnant women in Poland (the TOWER study).

Authors:  Jacek Smereka; Lukasz Szarpak; Kurt Ruetzler; Yehoshua Schacham; Adam Smereka; Marek Dabrowski; Marzena Terpilowska; Lukasz Terpilowski; Ishag Adam
Journal:  BMC Pregnancy Childbirth       Date:  2018-10-03       Impact factor: 3.007

Review 5.  Prevention and mitigation of congenital toxoplasmosis. Economic costs and benefits in diverse settings.

Authors:  Branko Bobić; Isabelle Villena; Eileen Stillwaggon
Journal:  Food Waterborne Parasitol       Date:  2019-06-01

6.  Estimates of Toxoplasmosis Incidence Based on Healthcare Claims Data, Germany, 2011-2016.

Authors:  Amrei Krings; Josephine Jacob; Frank Seeber; Uwe Pleyer; Jochen Walker; Klaus Stark; Hendrik Wilking
Journal:  Emerg Infect Dis       Date:  2021-08       Impact factor: 6.883

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.